Add time:08/29/2019         Source:sciencedirect.com

BackgroundAlthough several lines of recent studies fail to demonstrate the beneficial action of calcium antagonists, a novel dihydropyridine EFONIDIPINE (cas 111011-63-3), which possesses dilatory action of both afferent and efferent arterioles and, therefore, shares the renal microvascular action with angiotensin converting enzyme (ACE) inhibitors, is reported to exhibit renal protection in experimental animals.

We also recommend Trading Suppliers and Manufacturers of EFONIDIPINE (cas 111011-63-3). Pls Click Website Link as below: cas 111011-63-3 suppliers